Developer docs
API playgroundTry for free, no card

Search company profiles

Huntington Study Group

Full company profile

uuid000mvld

Namestring
Huntington Study Group
Legal namestring
Huntington Study Group
Company typeenum
Private
Founded yearint
1993
Short descriptiontext

Huntington Study Group is a Rochester, NY-based nonprofit founded in 1993 that conducts clinical trials and delivers research programs for Huntington's disease, serving pharmaceutical sponsors, academic investigators, and the HD patient community.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRochester, United States
HQ citystring
Rochester
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical trial research, Huntington's disease studies, neurological research consortium, observational clinical studies, clinical research services
Industry1 code
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Medical and Diagnostic Laboratories62151
SIC code3 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
  • Services-Health Services8000
Product category
Clinical Research Services
Social media profiles2 records
Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Huntington Study Group (HSG) is a non-profit clinical research consortium that designs, conducts, and coordinates clinical trials and observational studies focused on Huntington's disease. The organization provides research infrastructure across a network of clinical sites, collaborating with pharmaceutical sponsors, academic medical centers, and investigators to advance treatments and care standards for the disease.

Differentiator
Functional benefit
Problem solved
Product and service3 records
1Huntington's Disease Clinical Trials
CategoryClinical Research Services
Description

Design, coordination, and management of interventional clinical trials evaluating experimental therapies for Huntington's disease, delivered through a network of research sites for pharmaceutical and biotech sponsors.

2Observational Studies Program
CategoryClinical Research Services
Description

Long-term observational research programs enrolling and tracking Huntington's disease patients and family members to characterize disease progression and identify biomarkers, serving as a research platform for academic and industry collaborators.

3Research Site Network Services
CategoryClinical Research Services
Description

Operational and coordination services across a multi-site clinical research network, providing site management, training, and standardized study procedures for Huntington's disease research.

No data
Peers8 records
TypeDirect peer
Description

Private non-profit foundation exclusively focused on accelerating therapeutics for Huntington's disease; deeply comparable to HSG in mission (HD research) and non-profit structure, and a frequent collaborator/funder of HD clinical research.

TypeBroad incumbent
Description

Non-profit that develops regulatory-grade clinical trial tools and consortia across multiple disease areas including neurodegenerative disorders; comparable as a non-profit clinical-research enabler, though broader than HSG's HD-only focus.

3Clinical Research in Neurology (CRIN) - academic networks
TypeRegional player
Description

UK-based academic neurology trial network running multi-site studies in neurodegenerative conditions; comparable as a coordinated neurology trial network, though regionally focused outside HSG's primary US footprint.

TypeBroad incumbent
Description

Large global CRO with deep CNS and neurology trial capabilities; comparable as a clinical trial operator in HD-relevant indications, but vastly larger, commercial, and not disease-specific.

TypeDirect peer
Description

Largest US non-profit dedicated to Huntington's disease, combining patient advocacy, family services, and research support; directly comparable as a HD-focused non-profit that bridges patient community and research infrastructure.

TypeDirect peer
Description

Long-standing non-profit that funds research on Huntington's disease and other hereditary neurological disorders; comparable as a HD-focused research organization with similar scale and funding model.

7Cure Huntington's Disease Initiative (CHDI)
TypeDirect peer
Description

Major privately-funded biomedical organization devoted exclusively to rapidly developing therapeutics for Huntington's disease; comparable in disease focus and non-profit orientation but significantly larger in resources and scope.

TypeBroad incumbent
Description

Mid-sized full-service CRO with significant CNS/neurology franchise; comparable as a clinical trial execution provider in HD studies, though full-service rather than HD-specialized.

Market position
Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Huntington Study Group

Clinical Research Serviceshuntingtonstudygroup.org

Huntington Study Group is a Rochester, NY-based nonprofit founded in 1993 that conducts clinical trials and delivers research programs for Huntington's disease, serving pharmaceutical sponsors, academic investigators, and the HD patient community.

Huntington Study Group firmographics

Firmographics
Name
Huntington Study Group
Legal name
Huntington Study Group
Website
https://huntingtonstudygroup.org
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
11–50 employees
Short description
Huntington Study Group is a Rochester, NY-based nonprofit founded in 1993 that conducts clinical trials and delivers research programs for Huntington's disease, serving pharmaceutical sponsors, academic investigators, and the HD patient community.
Ownership category
akta.pro rank

Huntington Study Group industry classification

Industry
Product category
Clinical Research Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
akta.pro industry
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)

Keywords

  • Clinical trial research
  • Huntington's disease studies
  • Neurological research consortium
  • Observational clinical studies
  • Clinical research services

Where Huntington Study Group is headquartered

Location

Headquarters

HQ city
Rochester
HQ country
United States
HQ region
North America

Markets served

Huntington Study Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Huntington Study Group product offering

Product offering

Core offering

Huntington Study Group (HSG) is a non-profit clinical research consortium that designs, conducts, and coordinates clinical trials and observational studies focused on Huntington's disease. The organization provides research infrastructure across a network of clinical sites, collaborating with pharmaceutical sponsors, academic medical centers, and investigators to advance treatments and care standards for the disease.

Differentiator

Problem solved

Functional benefit

Products and services

  • Huntington's Disease Clinical Trials Design, coordination, and management of interventional clinical trials evaluating experimental therapies for Huntington's disease, delivered through a network of research sites for pharmaceutical and biotech sponsors.
  • Observational Studies Program Long-term observational research programs enrolling and tracking Huntington's disease patients and family members to characterize disease progression and identify biomarkers, serving as a research platform for academic and industry collaborators.
  • Research Site Network Services Operational and coordination services across a multi-site clinical research network, providing site management, training, and standardized study procedures for Huntington's disease research.

Companies that use Huntington Study Group

Customer profile

Ideal customer profiles2 records

Huntington Study Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Huntington Study Group competitors and assessment

Company assessment

Direct peers

  • CHDI Foundation: Private non-profit foundation exclusively focused on accelerating therapeutics for Huntington's disease; deeply comparable to HSG in mission (HD research) and non-profit structure, and a frequent collaborator/funder of HD clinical research.
  • Huntington's Disease Society of America (HDSA): Largest US non-profit dedicated to Huntington's disease, combining patient advocacy, family services, and research support; directly comparable as a HD-focused non-profit that bridges patient community and research infrastructure.
  • Hereditary Disease Foundation: Long-standing non-profit that funds research on Huntington's disease and other hereditary neurological disorders; comparable as a HD-focused research organization with similar scale and funding model.
  • Cure Huntington's Disease Initiative (CHDI): Major privately-funded biomedical organization devoted exclusively to rapidly developing therapeutics for Huntington's disease; comparable in disease focus and non-profit orientation but significantly larger in resources and scope.

Broad incumbents

  • Critical Path Institute (C-Path): Non-profit that develops regulatory-grade clinical trial tools and consortia across multiple disease areas including neurodegenerative disorders; comparable as a non-profit clinical-research enabler, though broader than HSG's HD-only focus.
  • Quintiles / IQVIA CNS Therapeutics: Large global CRO with deep CNS and neurology trial capabilities; comparable as a clinical trial operator in HD-relevant indications, but vastly larger, commercial, and not disease-specific.
  • Medpace: Mid-sized full-service CRO with significant CNS/neurology franchise; comparable as a clinical trial execution provider in HD studies, though full-service rather than HD-specialized.

Regional players

  • Clinical Research in Neurology (CRIN) - academic networks: UK-based academic neurology trial network running multi-site studies in neurodegenerative conditions; comparable as a coordinated neurology trial network, though regionally focused outside HSG's primary US footprint.

Market position

Customer concentration

Huntington Study Group social profiles

Digital presence

Huntington Study Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Huntington Study Group leadership team

Management profile

Number of profiles

Profiles1 record

Huntington Study Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Huntington Study Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Huntington Study Group

What does Huntington Study Group do?

Huntington Study Group (HSG) is a non-profit clinical research consortium that designs, conducts, and coordinates clinical trials and observational studies focused on Huntington's disease. The organization provides research infrastructure across a network of clinical sites, collaborating with pharmaceutical sponsors, academic medical centers, and investigators to advance treatments and care standards for the disease.

When was Huntington Study Group founded?

Huntington Study Group was founded in 1993. It employs 11 to 50 people.

Where is Huntington Study Group based?

Huntington Study Group is headquartered in Rochester, United States, in the North America region.

Who are Huntington Study Group's main competitors?

Direct peers on record are CHDI Foundation, Huntington's Disease Society of America (HDSA), Hereditary Disease Foundation and Cure Huntington's Disease Initiative (CHDI). Broad incumbents are Critical Path Institute (C-Path), Quintiles / IQVIA CNS Therapeutics and Medpace. Clinical Research in Neurology (CRIN) - academic networks is listed as a regional player.

Does Huntington Study Group have an API?

No public API is recorded for Huntington Study Group.

What industry is Huntington Study Group in?

Huntington Study Group's product category is Clinical Research Services. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
HuntingtonstudygroupCRO Services from HSGCR - From Trial Design to Product LaunchHSG Clinical Research, Inc., a wholly owned subsidiary of the Huntington Study Group, markets clinical research organization services spanning trial design, protocol leadership, execution, FDA inspection readiness and to-market support for Huntington's disease and related therapeutic areas. The company cites 40+ trials over 30+ years, 800+ HD expert members, 130+ trial-ready sites and 20,000+ participants.PR.comPhase III Clinical Study of Valbenazine for Chorea in Huntington Disease - PR.comThe Huntington Study Group announced the initiation of KINECT-HD, a Phase III study of valbenazine for chorea in Huntington disease. The 18-week, multi-center, randomized, double-blind, placebo-controlled study is enrolling participants at 55 centers across the U.S. and Canada. Valbenazine is FDA-approved for tardive dyskinesia.GlobeNewswireVerde Science to Sponsor/Present at the Huntington Study Group Annual ConferenceVerde Science will sponsor and present at the 23rd annual Huntington Study Group conference, held October 21-24, 2015, in Tampa, Florida. The company, which develops cannabis-based prescription medicines, said it is honored to support the event. The conference theme is 'Building Our Future.'GlobeNewswireNeuroSearch informs of the participation of the Huntington Study Group in the HART study with ACR16 in Huntington's diseaseThe Huntington Study Group announced a North American multi-centre HART study with NeuroSearch's ACR16 in Huntington's disease, enrolling 220 patients in a Phase IIb trial. The study, which began in October 2008, is part of a larger pivotal programme including a European Phase III study, with both expected to complete in the second half of 2009.